{"id":36671,"date":"2019-09-30T09:00:00","date_gmt":"2019-09-30T09:00:00","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=36671"},"modified":"2020-10-23T16:43:59","modified_gmt":"2020-10-23T16:43:59","slug":"htb-30-september-2019-online","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/36671","title":{"rendered":"HTB 30 September 2019 online"},"content":{"rendered":"<p class=\"HTBBODYtext\"><strong><span lang=\"EN-US\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-36678\" src=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2019\/09\/HTB-30-Sep-2019-cover-211x300.png\" alt=\"\" width=\"167\" height=\"234\" \/><\/span><\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/date\/2019\/09\" rel=\"noopener noreferrer\">Contents online<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2019\/09\/HTB-30-Sep-2019-no-11-1-column.pdf\" rel=\"noopener noreferrer\">PDF of this issue<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/forms\/esub.php\">Subscribe by email<\/a><\/li>\n<\/ul>\n<p class=\"HTBBODYtext\"><strong><span lang=\"EN-US\">This edition of HTB includes a few final reports from IAS 2019.<\/span><\/strong><\/p>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">We follow with news of first UK access (in Scotland) to the new two-drug combination of dolutegravir\/lamivudine and that the US FDA approve doravirine-based ART as a switch option.<\/span><\/p>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">A review paper from CID continues the evidence looking at whether integrase inhibitors are linked to weight gain &#8211; also reported from IAS 2019.<\/span><\/p>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">WHO have issued new guidelines for on-demand PrEP and joint UK guidelines cover the legal evidence to challenge HIV discrimination that is still sometimes reported at tattoo and beauty salons.<\/span><\/p>\n<p>Finally, two articles in other news, show community concerns about HIV services and the negative impact from lower uptake of the measles vaccination in the UK.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Final reports from IAS 2019, Scotland approves DTG\/3TC, WHO recommends event-based PrEP and more&#8230;<\/p>\n","protected":false},"author":3,"featured_media":36797,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-36671","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-editorial"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/36671","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=36671"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/36671\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media\/36797"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=36671"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=36671"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=36671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}